Xingxiao Pill Suppressed the Progression of Non-Small Cell Lung Cancer by Targeting SREBP1/FASN–Induced Fatty Acid Biosynthesis via PI3K/AKT/mTOR Signaling Pathway

Xingxiao Pill Suppressed the Progression of Non-Small Cell Lung Cancer by Targeting SREBP1/FASN–Induced Fatty Acid Biosynthesis via PI3K/AKT/mTOR Signaling Pathway

Xiangnan Zhou,1,2,* Xiuhua Hu,2,3,* Zhiying Zhang,2,* Shicheng Lin,2 Ximing Lin,2 Tian Zhou,2 Yanping Bai,1 Kaiwen Hu2 1Department of Dermatology, China-Japan Friendship Hospital, National Center for Integrated Traditional Chinese and Western Medicine, Beijing, 10...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhou X, Hu X, Zhang Z, Lin S, Lin X, Zhou T, Bai Y, Hu K
Format: Article
Language:English
Published: Dove Medical Press 2025-07-01
Series:Cancer Management and Research
Subjects:
Xingxiao Pill
PI3K/AKT/mTOR pathway
fatty acid biosynthesis
lung cancer
SREBP1
FASN
Online Access:https://www.dovepress.com/xingxiao-pill-suppressed-the-progression-of-non-small-cell-lung-cancer-peer-reviewed-fulltext-article-CMAR
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.dovepress.com/xingxiao-pill-suppressed-the-progression-of-non-small-cell-lung-cancer-peer-reviewed-fulltext-article-CMAR

Similar Items